Active	Status	Sponsor type	Region	Phase	Filter
6 Active 2 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Savassi, Leonardo
NCT04403100: Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"	Recruiting	3	1968	RoW	Hydroxychloroquine Sulfate Tablets, Lopinavir/ Ritonavir Oral Tablet, Hydroxychloroquine Sulfate Tablets plus Lopinavir/ Ritonavir Oral Tablets, Placebo	Cardresearch, Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA, Cytel Inc.	COVID-19, Coronavirus Infection, Virus Disease, Acute Respiratory Infection, SARS-CoV Infection	02/21	02/21
NCT04727424: Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms	Recruiting	3	7819	RoW	Spirulin Platensis, Budesonide Powder, Fluvoxamine Maleate 100 MG [Luvox], Fluoxetine 20 MG, Budesonide powder, Placebo	Cardresearch, Cytel Inc., McMaster University, Fastgrants, Eiger BioPharmaceuticals, RainWater Foundation	Covid19, SARS-Associated Coronavirus	06/24	07/24
REVIVE, NCT06128967: A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The Trial	Recruiting	3	1500	RoW	Fluvoxamine Maleate 100 MG, Placebo, Metformin Extended Release Oral Tablet	Cardresearch	Long COVID-19 Syndrome, Chronic Fatigue Syndrome	10/24	05/25
Milagres, Aline
NCT04727424: Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms	Recruiting	3	7819	RoW	Spirulin Platensis, Budesonide Powder, Fluvoxamine Maleate 100 MG [Luvox], Fluoxetine 20 MG, Budesonide powder, Placebo	Cardresearch, Cytel Inc., McMaster University, Fastgrants, Eiger BioPharmaceuticals, RainWater Foundation	Covid19, SARS-Associated Coronavirus	06/24	07/24
REVIVE, NCT06128967: A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With Long COVID-19: The Trial	Recruiting	3	1500	RoW	Fluvoxamine Maleate 100 MG, Placebo, Metformin Extended Release Oral Tablet	Cardresearch	Long COVID-19 Syndrome, Chronic Fatigue Syndrome	10/24	05/25
Correa, Vinicius
NCT04727424: Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms	Recruiting	3	7819	RoW	Spirulin Platensis, Budesonide Powder, Fluvoxamine Maleate 100 MG [Luvox], Fluoxetine 20 MG, Budesonide powder, Placebo	Cardresearch, Cytel Inc., McMaster University, Fastgrants, Eiger BioPharmaceuticals, RainWater Foundation	Covid19, SARS-Associated Coronavirus	06/24	07/24